Your browser doesn't support javascript.
loading
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.
Stern, Robert S; Divito, Sherrie J.
Afiliação
  • Stern RS; Beth Israel Deaconess Medical, Boston, Massachusetts, USA. Electronic address: rstern@bidmc.harvard.edu.
  • Divito SJ; Brigham and Women's Hospital Ringgold Standard Institution-Dermatology, Boston, Massachusetts, USA.
J Invest Dermatol ; 137(5): 1004-1008, 2017 05.
Article em En | MEDLINE | ID: mdl-28411832
ABSTRACT
Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made in understanding the causes and pathobiology of this often life-threatening condition. Su et al demonstrate associations between IL 15 serum levels and the outcome of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Their findings provide ideas for further investigations that may help us better understand the role of cytokines in this T-cell mediate disease and provides clues to possible new therapies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Aguda / Síndrome de Stevens-Johnson Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Aguda / Síndrome de Stevens-Johnson Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2017 Tipo de documento: Article